4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-23-015701
Director sold 25,000 shares at $12.57 ($314,250)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2023-11-30 | Sale 10b5-1 | −25,000 | $12.57 | $314,250 | 926,283 | D |
| Open-market sales · 25,000 sh · avg $12.57 · $314,250 | |||||||
Loading xslF345X05/form4-12012023_051201.xml…